BOT 3.68% 32.8¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-66

  1. 4,077 Posts.
    lightbulb Created with Sketch. 477
    Meeting with the FDA will be interesting. Might be set up for a replication of the PhaseII study, meaning funding would need to be obtained and a delay for the phase III
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.8¢
Change
-0.013(3.68%)
Mkt cap ! $606.3M
Open High Low Value Volume
34.0¢ 34.0¢ 32.5¢ $970.1K 2.922M

Buyers (Bids)

No. Vol. Price($)
28 1093521 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 68488 4
View Market Depth
Last trade - 13.37pm 08/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.